HISA Medication Rules: Withdrawal Guidelines Released By Racing Medication And Testing Consortium

Long Version of the Guidance (10 Pages)

Short Version of the Guidance (4 Pages)

Hard Copies are available at the ITHA office.

Withdrawal guidelines are for informational purposes only. It is advisable that this information should be used by horsemen in consultation with their attending veterinarian. The withdrawal guidelines do not constitute a guarantee or warranty.

HISA's expected ADMC implementation date is March 27, 2023.

Also, the Withdrawal Guidance is subject to change. As new research becomes available for each medication, the RMTC may extend or decrease the time listed in the Withdrawal Guidance. Any subsequent change in this information based upon new research will be provided upon review by the Scientific Advisory Committee and approval by the RMTC Board.

The RMTC is a 501(c) 3 organization comprised of 23 industry stakeholder organizations with a shared commitment to engage in research, education, and advocacy for science-based initiatives that promote the health and safety of the racehorse and the integrity of the competition. More information can be found at RMTCnet.com